Atea Pharmaceuticals, Inc.
AVIR
DELAYED 1 MONTH
3 insider filings · Latest: May 18, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 18, 2026 | May 21 10:30 PM | Polly A. MurphyDirector | Purchase | 6,100 | $4.17 | $25.4K | 92,145(D) | View → |
| May 18, 2025 | May 20 8:15 PM | Polly A. MurphyDirector | Purchase | 6,100 | $4.17 | $25.4K | 92,145(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 11, 2026 | Mar 13 10:00 PM | Andrea CorcoranChief Financial Officer, Executive Vice President, Legal and Secretary | Option Exercise | 60,000 | $1.24 | 0(D) | View → |